Real-world evidence for frequency of constipation with the use of anti-CGRP monoclonal antibodies in chronic migraine

被引：0
|
作者：
Uzun, S. [1 ,2 ]
Frejvall, U. [1 ]
Sahin, G. Ozkaya [3 ,4 ]
Sahin, G. [1 ,2 ]
机构：
[1] Skaneuro Neurol Clin, Lund, Sweden
[2] Lund Univ, Dept Clin Sci Malmo & Lund, Lund, Sweden
[3] Lund Univ, Dept Lab Med, Lund, Sweden
[4] Lund Univ, Dept Translat Med, Lund, Sweden
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P015
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Synergism of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in the treatment of migraine
    Hennessy, E.
    Salim, A.
    Biswas, S.
    Sonneborn, C.
    Hogue, O.
    Suneja, A.
    Mays, M.
    Ahmed, Z.
    Mata, I
    HEADACHE, 2023, 63 : 170 - 171
  • [32] Ketogenic Diet in resistant chronic migraine with failure to anti-CGRP monoclonal antibodies (KETOMIGRAINE)
    Ahmad, L.
    Allena, M.
    Tassorelli, C.
    Sances, G.
    Vaghi, G.
    Guaschino, E.
    Ghiotto, N.
    De Icco, R.
    Rondanelli, M.
    Mansueto, F.
    Barrile, G.
    Nichetti, M.
    Znaboni, A.
    Demartini, C.
    Greco, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 148 - 148
  • [33] Switching OnabotulinumtoxinA to Monoclonal Anti-CGRP Antibodies in Drug-Resistant Chronic Migraine
    Luigi Francesco Iannone
    Davide Fattori
    Martina Marangoni
    Silvia Benemei
    Alberto Chiarugi
    Pierangelo Geppetti
    Francesco De Cesaris
    CNS Drugs, 2023, 37 : 189 - 202
  • [34] Switching OnabotulinumtoxinA to Monoclonal Anti-CGRP Antibodies in Drug-Resistant Chronic Migraine
    Iannone, Luigi Francesco
    Fattori, Davide
    Marangoni, Martina
    Benemei, Silvia
    Chiarugi, Alberto
    Geppetti, Pierangelo
    De Cesaris, Francesco
    CNS DRUGS, 2023, 37 (02) : 189 - 202
  • [35] Partial and nonresponders to onabotulinumtoxinA can benefit from anti-CGRP monoclonal antibodies preventive treatment: A real-world evidence study
    Alpuente, Alicia
    Gallardo, Victor J.
    Caronna, Edoardo
    Torres-Ferrus, Marta
    Pozo-Rosich, Patricia
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (07) : 2378 - 2382
  • [36] Anti-CGRP and Anti-CGRP Receptor Monoclonal Antibodies for Migraine Prophylaxis: Retrospective Observational Study on 209 Patients
    Schweiger, Vittorio
    Bellamoli, Paola
    Taus, Francesco
    Gottin, Leonardo
    Martini, Alvise
    Nizzero, Marta
    Bonora, Eleonora
    Del Balzo, Giovanna
    Donadello, Katia
    Secchettin, Erica
    Finco, Gabriele
    De Santis, Daniele
    Polati, Enrico
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (04)
  • [37] Anti-CGRP monoclonal antibodies: migraine prevention in patients with psychiatric comorbidities
    di Cola, Francesca Schiano
    Ceccardi, Giulia
    Caratozzolo, Salvatore
    Bolchini, Marco
    Di Pasquale, Michele
    Rao, Renata
    Padovani, Alessandro
    CEPHALALGIA, 2023, 43 (1supp) : 252 - 253
  • [38] Safety concerns of treatment with anti-CGRP monoclonal antibodies in patients with migraine
    van der Arend, Britt W. H.
    van Veelen, Nancy
    de Ruijter, Joelle E. T.
    Olsen, Michael H.
    van den Brink, Antoinette Maassen
    Terwindt, Gisela M.
    CEPHALALGIA, 2023, 43 (1supp) : 233 - 233
  • [39] Personality traits and efficacy of anti-CGRP monoclonal antibodies in migraine prevention
    Lovati, Carlo
    Bernasconi, Gianna
    Capogrosso, Chiara
    Molteni, Laura
    Giorgetti, Federica
    Dell'Osso, Bernardo
    Pantoni, Leonardo
    NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5765 - 5767
  • [40] Personality traits and efficacy of anti-CGRP monoclonal antibodies in migraine prevention
    Carlo Lovati
    Gianna Bernasconi
    Chiara Capogrosso
    Laura Molteni
    Federica Giorgetti
    Bernardo Dell’Osso
    Leonardo Pantoni
    Neurological Sciences, 2022, 43 : 5765 - 5767
12345